Onco Wiki / Indication

Endometrial carcinoma · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Trackstandard
Linked regimenNone
IDIND-IATROGENIC-TAMOXIFEN-ENDOMETRIAL-PREVENTION-SURVEILLANCE
TypeIndication
Statusreviewed 2026-05-18 | pending_clinical_signoff
DiseasesDIS-ENDOMETRIAL
SourcesSRC-NCCN-BREAST-2025 SRC-NCCN-UTERINE-2025

Notes

STUB — v0.3 iatrogenic prevention pilot (tamoxifen endometrial). Two-Clinical-Co-Lead signoff queued. Critical: routine TVUS screening NOT recommended; symptom-prompted evaluation is the standard.

Used By

Contraindications